292 related articles for article (PubMed ID: 21394517)
1. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
Ikota H; Tanaka Y; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
Gyure KA; Morrison AL
Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
[TBL] [Abstract][Full Text] [Related]
3. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
4. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
Calder KB; Coplowitz S; Schlauder S; Morgan MB
J Cutan Pathol; 2007 Dec; 34(12):918-23. PubMed ID: 18001414
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
6. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
Su YC; Hsu YC; Chai CY
Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7 and 20 expression in gallbladder carcinoma.
Kalekou H; Miliaras D
Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103
[TBL] [Abstract][Full Text] [Related]
8. Epithelial and organ-related marker expression in pituitary adenomas.
Cykowski MD; Takei H; Baskin DS; Rivera AL; Powell SZ
Neuropathology; 2016 Aug; 36(4):354-64. PubMed ID: 26991787
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
10. Tubular carcinoids of the appendix: the CK7/CK20 immunophenotype can be a diagnostic pitfall.
Matsukuma KE; Montgomery EA
J Clin Pathol; 2012 Jul; 65(7):666-8. PubMed ID: 22461652
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
13. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
[TBL] [Abstract][Full Text] [Related]
14. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
Park SY; Kim HS; Hong EK; Kim WH
Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
[TBL] [Abstract][Full Text] [Related]
17. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
18. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
Beschorner R; Schittenhelm J; Schimmel H; Iglesias-Rozas JR; Herberts T; Schlaszus H; Meyermann R; Wehrmann M
Hum Pathol; 2006 Jul; 37(7):854-60. PubMed ID: 16784985
[TBL] [Abstract][Full Text] [Related]
19. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
Tsao SC; Su YC; Wang SL; Chai CY
Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
